Literature DB >> 26558623

[S3 guidelines on long-term opioid treatment in non-cancer pain. Recommendations for opioid use in clinical rheumatology].

M Krasselt1, W Häuser2,3, F Petzke4, C Baerwald5.   

Abstract

The long-term use of opioids for chronic pain can be problematic in many respects. Besides potentially harmful and considerable undesired side effects and possible drug abuse, the indications for prescription, efficacy and safety in the long run have to be considered. The recently updated S3 guidelines on long-term opioid treatment in non-cancer pain (LONTS) provide recommendations with the highest currently available evidence. This article summarizes the most relevant contents for the clinical rheumatologist.

Entities:  

Keywords:  Chronic lower back pain; Osteoarthritis; Rheumatoid arthritis; Rheumatology; Treatment recommendations

Mesh:

Substances:

Year:  2016        PMID: 26558623     DOI: 10.1007/s00393-015-1686-y

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  16 in total

1.  [Soft tissue rheumatic syndromes and treatment of pain].

Authors:  M Krasselt; C Baerwald
Journal:  Dtsch Med Wochenschr       Date:  2013-11-26       Impact factor: 0.628

2.  Long-term opioid use in non-cancer pain.

Authors:  Winfried Häuser; Fritjof Bock; Peter Engeser; Thomas Tölle; Anne Willweber-Strumpfe; Frank Petzke
Journal:  Dtsch Arztebl Int       Date:  2014-10-24       Impact factor: 5.594

Review 3.  Epidemiology of hip and knee osteoarthritis.

Authors:  D T Felson
Journal:  Epidemiol Rev       Date:  1988       Impact factor: 6.222

Review 4.  The effect of opioid therapy on endocrine function.

Authors:  Michael J Brennan
Journal:  Am J Med       Date:  2013-03       Impact factor: 4.965

5.  The current relevance and use of prednisone in rheumatoid arthritis.

Authors:  Marco Krasselt; Christoph Baerwald
Journal:  Expert Rev Clin Immunol       Date:  2014-04-09       Impact factor: 4.473

Review 6.  [Opioids in chronic noncancer pain-are opioids superior to nonopioid analgesics? A systematic review and meta-analysis of efficacy, tolerability and safety in randomized head-to-head comparisons of opioids versus nonopioid analgesics of at least four week's duration].

Authors:  P Welsch; C Sommer; M Schiltenwolf; W Häuser
Journal:  Schmerz       Date:  2015-02       Impact factor: 1.107

Review 7.  [Opioids in chronic osteoarthritis pain. A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration].

Authors:  R Schaefert; P Welsch; P Klose; C Sommer; F Petzke; W Häuser
Journal:  Schmerz       Date:  2015-02       Impact factor: 1.107

Review 8.  [Opioids in chronic low back pain. A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration].

Authors:  F Petzke; P Welsch; P Klose; R Schaefert; C Sommer; W Häuser
Journal:  Schmerz       Date:  2015-02       Impact factor: 1.107

Review 9.  Exercise therapy for treatment of non-specific low back pain.

Authors:  J A Hayden; M W van Tulder; A Malmivaara; B W Koes
Journal:  Cochrane Database Syst Rev       Date:  2005-07-20

10.  [The prevalence of pain in the elderly German population: results of population-based studies with the Giessen Subjective Complaints List (Giessener Beschwerdebogen GBB)].

Authors:  T Gunzelmann; J Schumacher; E Brähler
Journal:  Schmerz       Date:  2002-08       Impact factor: 1.107

View more
  4 in total

Review 1.  Current State of Opioid Therapy and Abuse.

Authors:  Laxmaiah Manchikanti; Adam M Kaye; Alan D Kaye
Journal:  Curr Pain Headache Rep       Date:  2016-05

2.  [Prescription of analgesics in patients with rheumatic diseases in Germany : A claims data analysis. German version].

Authors:  K Albrecht; U Marschall; J Callhoff
Journal:  Z Rheumatol       Date:  2021-02-26       Impact factor: 1.372

3.  [Diagnostics and therapy in children and adolescents with chronic pain : Trends in interventions potentially dangerous to health].

Authors:  Felix Selent; Sabrina Schenk; Dunja Genent; Julia Wager; Boris Zernikow
Journal:  Schmerz       Date:  2020-11-13       Impact factor: 1.107

4.  Prescription of analgesics in patients with rheumatic diseases in Germany : A claims data analysis.

Authors:  K Albrecht; U Marschall; J Callhoff
Journal:  Z Rheumatol       Date:  2021-04-07       Impact factor: 1.372

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.